Merck's Fosamax Plus D To Be Priced On Par With Predecessor
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck's Fosamax Plus D adds weekly dose of vitamin D to the once-weekly osteoporosis agent. Plus D will reach the market around the same time as Roche/GlaxoSmithKline's once-monthly Boniva.